Legal Representation
Attorney
Christie Baty Hudgins
USPTO Deadlines
Next Deadline
147 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
December 30, 2025
Extension Available
Until December 30, 2025
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 21, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 20, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 20, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 20, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 31, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 19, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 19, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 13, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 11, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 7, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 2, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jul 2, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 5, 2024 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Apr 5, 2024 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Apr 5, 2024 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Apr 2, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 5, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 4, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 6, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for gene therapy; pharmaceutical preparations that use genome editing to treat genetic, oncological, and immune system disorders and diseases
Additional Information
Design Mark
The mark consists of a stylized representation of a gene being inserted into the human genome, made of three columns of broken vertical line.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005